Massimo Loda

49PUBLICATIONS
388CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Gene expression (incl. microarray and other genome-wide approaches)Systems physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Jul 01, 2026
Retraction Note: NSD2 targeting reverses plasticity and drug resistance in prostate cancer.

|Apr 03, 2026
Suppression of de novo lipogenesis and dietary PUFA supplementation inhibit prostate cancer progression.

Silvia D Rodrigues, Caroline Fidalgo Ribeiro, Giuseppe N Fanelli

|Mar 13, 2026
Lipidomic profiling in metastatic prostate cancer captures tumor metabolic rewiring and its modulation by androgen receptor-targeting therapy.

Sara Bleve, Francesco Ravera, Silvia Rodrigues

|Nov 26, 2025
NSD2 targeting reverses plasticity and drug resistance in prostate cancer.

Jia J Li, Alessandro Vasciaveo, Dimitris Karagiannis

|Nov 24, 2025
Multi-omics integration and batch correction using a modality-agnostic deep learning framework.

Jose Ignacio Alvira Larizgoitia, Gabriele Partel, Lorenzo Venturelli

|Oct 02, 2025
Pathogenic variants reveal candidate genes for prostate cancer germline testing for men of African ancestry.

Kazzem Gheybi, Pamela X Y Soh, Jue Jiang

Pageof 9

Frequent Collaborators

10 joint publications

Kenneth C Anderson

10 joint publications

Lewis C Cantley

9 joint publications

Luis A Diaz

9 joint publications

Chi Van Dang